Rockville, Maryland — According to state and local economic development sources Vigene Biosciences plans to build out 52,000 square feet of new space in Rockville. The company plans to occupy the new space at 14200 Shady Grove Road in Rockville, on or about September 1, 2021. According to the company website Vigene Biosciences was founded in 2012 by senior scientists with expertise in the fields of virology and gene therapy. At Vigene, we strive to be the leading supplier of gene delivery technologies with the mission to advance biomedical research and to make gene therapy affordable. We offer both research-grade and cGMP-grade AAV, lentivirus, and adenovirus-based products and custom services. Some of our product offerings include ready-to-ship genome wide human cDNA ORFs on adenoviral or lentiviral vectors, AAV shRNA constructs, pre-made control GFP viruses, AAV biosensors developed in partnership with Janelia Research Campus, AAV alpha-synuclein vectors developed in partnership with The Michael J Fox Foundation, and many others.

To learn more about Vigene Biosciences, visit http://www.vigenebio.com/

Company Contact:
Zairen Sun, Chief Executive Officer
301-251-6638

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved